Karim Mikhail

Mr. Mikhail joined Amarin in July 2020 as senior vice president commercial head Europe and was promoted to president and chief executive officer in August 2021. Prior to Amarin, he served as chief executive officer of Theodon, a global commercial strategy consultancy that he founded in 2018. Prior to that, he was with Merck for 22 years, in a career spanning seven different countries across three continents. His most recent role was global commercial leader for Merck’s $4 billion lipid franchise. Prior to that Mr. Mikhail was also chief marketing officer for Europe, Middle East and Africa and chief operating officer for emerging markets. While at Merck, Mr. Mikhail led the successful commercial launch of dozens of products, including ezetimibe and various molecules in diabetes, hypertension, immunology, and oncology.